Clinical Trials Browser

Phase 1/2 × Squamous Cell Carcinoma of Head and Neck × elgemtumab × Clear all

NCT02143622 2016-04-21

Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients

Phase 1/2 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms